Figure 3.

IC₅₀ values comparison between free form and drug encapsulated solid lipid nanoparticles (SLNs). In MIA PaCa-2 cells, IC₅₀ values were compared between free and SLN forms of (A) aspirin and (B) curcumin. In Panc-1 cells, IC₅₀ comparisons were shown between free and SLN forms of (C) aspirin and (D) curcumin. MTS assay was performed to determine the cell viability of MIA PaCa-2 and Panc-1 cells after treating with a range of concentrations of free and SLN forms of aspirin and curcumin for 72 h. IC₅₀ values were then determined using graphpad Prism software.